Health Canada

• Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

  Collaborator, Phase 2, Recruiting, 84 people, 8 May 2026

• NCT01022229

  Collaborator, Phase 3, Completed, 16 people, 1 Dec 2009

Sources: clinicaltrials.gov

• Influence of the COVID-19 pandemic on breast cancer outcomes: A microsimulation model of the National Mammography Database

  10 Aug 2026

• Serum endothelial monocyte-activating polypeptide-II response after 9 h of passive heat exposure: influence of age, diabetes, or hypertension

  4500387992, 9 Jan 2026

Sources: api.crossref.org

• Tirzepatide (Zepbound): Indication: For once-weekly administration for chronic weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of: 30 kg/m2 or greater (obesity), or 27 kg/m2 to less than 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, prediabetes, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease): Reimbursement Recommendation

  Canadian Agency for Drugs and Technologies in Health, Ottawa (ON), 30 Sept 2026

• The Shifting Landscape of Natural Health Product Licensing in Canada: The e-Commerce Case of Stem Cell Supplements

  Interactive journal of medical research, 29 Sept 2026

• Drug and Natural Health Product Data Collection and Curation in the Canadian Longitudinal Study on Aging

  Canadian journal on aging = La revue canadienne du vieillissement, 25 Jan 2024

• Testosterone treatment and cardiovascular and venous thromboembolism risk: what is 'new'?

  Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 10 May 2017